[1] Mohammed Faraz, Fairozekhan Arishiya T. Oral Leukoplakia. StatPearls, 25 August2020.Bookshelf ID: NBK442013
[2] Acpda B, Jcdab C, Hfda B, et al.Malignant transformation rate of oral leukoplakia—systematic review[J]. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2020, 129( 6):600-611.DOI: 10.1016/j.oooo.2020.02.017
[3] Ramirez-Garcia A, Rementeria A, Aguirre-Urizar J M, et al. Candida albicans and cancer: Can this yeast induce cancer development or progression?[J]. Critical Reviews in Microbiology, 2014(2):1-13.DOI: 10.3109/1040841X.2014.913004
[4] Sarkar R, Rathod G .Clinicopathologic assessment of Candida colonization of oral leukoplakia[J]. Indian Journal of Dermatology, 2014, 80(5):413-418.DOI: 10.4103/0378-6323.140299
[5] Gupta V, Abhisheik K, Balasundari S, et al.Identification of Candida albicans using different culture media and its association in leukoplakia and oral squamous cell carcinoma[J]. Journal of Oral and Maxillofacial Pathology, 2019, 23(1):28-35.DOI: 10.4103/jomfp.JOMFP_157_18
[6] 许子元, 魏本娟, 施琳俊,等. 口腔黏膜白斑与念珠菌感染的临床分析[J]. 临床口腔医学杂志, 2014, 000(010):625-626,627.
[7] Dany A, Kurian K, Shanmugam S .Association of Candida in Different Stages of Oral Leukoplakia[J]. Indian Academy of Oral Medicine and Radiology, 2011, 23(1):14-16.DOI: 10.5005/jp-journals-10011-1081
[8] Dorko E, M Zibrín, Jenca A, et al. The histopathological characterization of oral Candida leukoplakias[J]. Folia Microbiologica, 2001, 46(5):447-451.DOI: 10.1007/BF02814437
[9] Sanjaya P R, Gokul S, Patil B G, et al.Candida in oral pre-cancer and oral cancer[J]. Medical Hypotheses, 2011, 77(6):1125-1128.DOI: 10.1016/j.mehy.2011.09.018
[10] Pina P, M Custódio, Sugaya N N, et al. Histopathologic aspects of the so-called chronic hyperplastic candidiasis: An analysis of 36 cases[J]. Journal of Cutaneous Pathology, 2020(5):66-71.DOI: 10.1111/cup.13875
[11] Bánóczy, Jolán.Follow-up studies in oral leukoplakia[J]. J Maxillofac Surg, 1977, 5:69-75.DOI: 10.1016/s0301-0503(77)80079-9
[12] Chiang W, Liu S, Lin J, et al.Malignant development in patients with oral potentially malignant disorders detected through nationwide screening: Outcomes of 5-year follow-up at a single hospitall[J]. Head & Neck, 2019, 42(1):67-76.DOI: 10.1002/hed.25973
[13] Tamgadge S, Tamgadge A, Pillai A, et al.Association of Candida sp. with the Degrees of Dysplasia and Oral Cancer: A Study by Calcofluor White under Fluorescent Microscopy[J]. Iranian Journal of Pathology, 2017, 12(14):348-355.
[14] Castillo G, Blanc S, Sotomayor C E, et al.Study of virulence factor of Candida species in oral lesions and its association with potentially malignant and malignant lesions[J]. Archives of Oral Biology, 2018,91:35-41.DOI: 10.1016/j.archoralbio.2018.02.012
[15] AD Alnuaimi, D Wiesenfeld, NM O’Brien-Simpson, et al. Oral Candida colonization in oral cancer patients and its relationship with traditional risk factors of oral cancer: A matched case-control study[J]. Oral Oncology, 2015, 51(2):139-145.DOI: 10.1016/j.oraloncology.2014.11.008
[16] Mccullough M, Jaber M, Barrett A W, et al.Oral yeast carriage correlates with presence of oral epithelial dysplasia[J]. Oral Oncology, 2002, 38(4):391-393.DOI: 10.1016/s1368-8375(01)00079-3
[17] Daftary D K, Mehta F S, Gupta P C, et al.The presence of Candida in 723 oral leukoplakias among Indian villagers[J]. European Journal of Oral Sciences, 2010, 80(1):75-79.DOI: 10.1111/j.1600-0722.1972.tb00265.x
[18] Mathur H .Correlation of Presence of Candida and Epithelial Dysplasia in Oral Mucosal Lesions[J]. Journal of Clinical & Diagnostic Research, 2014, 8(10):31-35.DOI: 10.7860/JCDR/2014/9872.4956
[19] Speight P M, Khurram S A, Kujan O .Oral potentially malignant disorders: risk of progression to malignancy[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2017,125(6):612-627.DOI: 10.1016/j.oooo.2017.12.011
[20] Millsop J W, Fazel N .Oral candidiasis.[J]. Clinics in Dermatology, 2016, 34(4):487-494.DOI: 10.1016/j.clindermatol.2016.02.022
[21] Al A, Aviv Ouanounou BSc, MSc, DDS, FICD, FACD, FICO b. Fungal infections in dentistry: Clinical presentations, diagnosis, and treatment alternatives[J]. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2020, 130(5):533-546.DOI: 10.1016/j.oooo.2020.08.011
[22] Schmidt-Westhausen, A.M., 103 - Medical Management of Oral Mucosal Lesions. Maxillofacial Surgery, 2017,1544-1555.DOI: 10.1016/B978-0-7020-6056-4.00103-9
[23] Warnakulasuriya S .Oral potentially malignant disorders: A comprehensive review on clinical aspects and management[J]. Oral Oncology, 2020,102(3).DOI: 10.1016/j.oraloncology.2019.104550
[24] Dilhari A, Weerasekera M M, Siriwardhana A, et al.Candida infection in oral leukoplakia: an unperceived public health problem[J]. Acta Odontologica Scandinavica, 2016, 74(7):565-569.DOI: 10.1080/00016357.2016.1220018
[25] Coimbra F, Rocha M M, Oliveira V C, et al.Antimicrobial activity of effervescent denture tablets on multispecies biofilms[J]. Gerodontology, 2020,38(1):87-94.DOI: 10.1111/ger.12500
[26] Krogh P, Holmstrup P, Thorn J J, et al.Yeast species and biotypes associated with oral leukoplakia and lichen planus[J]. Oral Surgery Oral Medicine Oral Pathology, 1987, 63(1):48-54.DOI: 10.1016/0030-4220(87)90339-2
[27] Mcmanus B, Coleman D .Genotyping Candida albicans from Candida Leukoplakia and Non-Candida Leukoplakia Shows No Enrichment of Multilocus Sequence Typing Clades but Enrichment of ABC Genotype C in Candida Leukoplakia[J]. PLoS ONE, 2013, 8(9):e73738.DOI: 10.1371/journal.pone.0073738
[28] Anna M, Ali N, Antti M, et al.Role of Non-Albicans Candida and Candida Albicans in Oral Squamous Cell Cancer Patients[J]. Journal of Oral and Maxillofacial Surgery, 2018, 76:2564-2571.DOI: 10.1016/j.joms.2018.06.012
[29] Negi M .Prevalence of oral parameters in smokeless tobacco-associated precancer[J]. Journal of Family Medicine and Primary Care, 2019, 8(12):3956-3961.DOI: 10.4103/jfmpc.jfmpc_667_19
[30] Nieminen M T, Uittamo J, Salaspuro M, et al.Acetaldehyde production from ethanol and glucose by non-Candida albicans yeasts in vitro[J]. Oral Oncology, 2009, 45(12):e245-e248.DOI: 10.1016/j.oraloncology.2009.08.002
[31] Abdrazak A, Aine W, Al-Hebshi Nezar N, et al. Acetaldehyde production by Rothia mucilaginosa isolates from patients with oral leukoplakia[J]. Journal of Oral Microbiology, 2020, 12(1):e245-e248.DOI: 10.1080/20002297.2020.1743066
[32] Fan H, Yuefeng S,Wei C, et al.Effects of Candida albicans infection on defense effector secretion by human oral mucosal epithelial cells[J]. Archives of Oral Biology, 2019, 103: 55-61.DOI: 10.1016/j.archoralbio.2019.05.013
[33] Verma A H, Richardson J P, Zhou C, et al. Oral epithelial cells orchestrate innate type 17 responses to Candida albicans through the virulence factor candidalysin[J]. Science Immunology, 2017, 2(17):eaam8834.DOI: 10.1126/sciimmunol.aam8834
[34] Sitheeque M, Samaranayake L .Chronic Hyperplastic Candidosis/Candidiasis (Candidal Leukoplakia)[J]. Crit Rev Oral Biol Med, 2003, 14(4):253.DOI: 10.1177/154411130301400403
[35] Gholizadeh P, Eslami H, Yousefi M, et al.Role of oral microbiome on oral cancers, a review[J]. Biomedicine & Pharmacotherapy, 2016, 84:552-558.DOI: 10.1016/j.biopha.2016.09.082
[36] Amer A, Galvin S, Healy C M, et al.The Microbiome of Potentially Malignant Oral Leukoplakia Exhibits Enrichment for Fusobacterium, Leptotrichia, Campylobacter, and Rothia Species[J].Microbiology, 2017, 8.DOI: 10.3389/fmicb.2017.02391
[37] Villa A, Sonis S .Oral leukoplakia remains a challenging condition[J]. Oral Diseases, 2018, 24(1-2):179-183.DOI: 10.1111/odi.12781
[38] Qin L, Mz A, Wei C, et al.Mainstream cigarette smoke induces autophagy and promotes apoptosis in oral mucosal epithelial cells[J]. Archives of Oral Biology,2020,111.DOI: 10.1016/j.archoralbio.2019.104646
[39] Qian Y, Jiang W, Wang X, et al.Expression of nucleotide-binding oligomerization domain 1, nuclear factor-kappa B and human beta-defensins in candidal albicans leukoplakia.[J].Chinese journal of stomatology, 2014, 49(8):464-469.DOI: 10.3760/cma.j.issn.1002-0098.2014.08.004
[40] Wielen P, Holmes A R, Cannon R D .Secretory component mediates Candida albicans binding to epithelial cells[J]. Oral Diseases, 2015, 22(1):69-74.DOI: 10.1111/odi.12397
[41] Mahalakshmi K, Leenasankari S, Gayathri K .Oral candidal carriage and their antifungal susceptibility pattern in potentially malignant disorders[J]. International Journal of Infectious Diseases,2016,45.DOI:10.1016/j.ijid.2016.02.687
[42] Daniels T E, Sehwartz O, Larsen V, et al.Langerhans cells in candidal leukoplakia.[J]. Journal of Oral Pathology, 1985,14(9):733-739. DOI: 10.1111/j.1600-0714.1985.tb00552.x
[43] Abiko Y, Jinbu Y, Noguchi T, et al.Upregulation of human beta-defensin 2 peptide expression in oral lichen planus, leukoplakia and candidiasis. an immunohistochemical study[J]. Pathology Research & Practice, 2002, 198(8):537-542.DOI: 10.1078/0344-0338-00298
[44] Upadhyay J, Upadhyay R B, Agrawal P, et al.Langerhans Cells and Their Role in Oral Mucosal Diseases[J]. North American Journal of Medical Sciences, 2013, 5(9):505-514.DOI: 10.4103/1947-2714.118923
[45] Dalle F, Wächtler B, L’Ollivier C, et al. Cellular interactions of Candida albicans with human oral epithelial cells and enterocytess[J]. Cellular Microbiology, 2010,12(2):248-71.DOI: 10.1111/j.1462-5822.2009.01394.x
[46] Lehner T, Wilton J, Shillitoe E J, et al.Cell-mediated Immunity and Antibodies to Herpesvirus hominis Type 1 in Oral Leukoplakia and Carcinoma[J]. British Journal of Cancer,1973,27:351-361.DOI: 10.1038/bjc.1973.43
[47] Conti H, Bruno V, Childs E, et al.IL-17 Receptor Signaling in Oral Epithelial Cells Is Critical for Protection against Oropharyngeal Candidiasis[J]. Cell Host & Microbe, 2016:606-617.DOI: 10.1016/j.chom.2016.10.001
[48] Ran C, Li D, Shi X, et al.Reduced CX3CL1 Secretion Contributes to the Susceptibility of Oral Leukoplakia-Associated Fibroblasts to Candida albicans[J]. Frontiers in Cellular and Infection Microbiology, 2016, 6.DOI: 10.3389/fcimb.2016.00150
[49] Ye P, Wang X, Ge S, et al.Long-term cigarette smoking suppresses NLRP3 inflammasome activation in oral mucosal epithelium and attenuates host defense against Candida albicans in a rat model[J]. Biomedicine & Pharmacotherapy, 2019, 113.DOI: 10.1016/j.biopha.2019.01.058 |
